Pharmerica (PMC) Tops Q4 EPS by 2c

Pharmerica (NYSE: PMC) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $523.5 million versus the consensus estimate of $491.99 million.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• IDEX Corporation to Webcast Third Quarter 2026 Earnings Call
• ZoomInfo Technologies (GTM) PT Lowered to $4.25 at DA Davidson to Reflect Sector Headwinds